ADMA Biologics Inc vs Veritone Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Veritone Inc trades at $1.49 (market cap $138.04M). The key difference: ADMA Biologics Inc is far larger — about 16.1× Veritone Inc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | VERI | |
|---|---|---|
Market Cap | $2.22B | $138.04M |
Sector | Health | Technology |
52-Week High | $20.38 | $8.39 |
52-Week Low | $7.60 | $1.00 |
Enterprise Value | $2.29B | $170.07M |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →